Publications by authors named "B Leeneman"

Claim this Profile
D
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma.
Saskia de Groot, Hedwig M Blommestein, Brenda Leeneman, Carin A Uyl-de Groot, John B A G Haanen

Med Decis Making· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model.
Hedwig M Blommestein, Saskia de Groot, Brenda Leeneman, Carin A Uyl-de Groot, John B A G Haanen

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
N S H Xander, B Leeneman, A-M C Dingemans, W E Fiets, W K de Jong

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival in Patients With Advanced Melanoma.
Olivier J van Not, Alfons J M van den Eertwegh, Hilde Jalving, Manja Bloem, John B Haanen, Brenda Leeneman

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness.
Brenda Leeneman, Nicolas S H Xander, W Edward Fiets, Wouter K de Jong, Nathalie E M Uyl

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis